Market Chameleon (Tue, 11-Aug 3:32 AM ET)
P3 Health Partners Announces Second Quarter 2026 Results
Business Wire (Mon, 10-Aug 4:05 PM ET)
P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call
Business Wire (Tue, 21-Jul 4:05 PM ET)
P3 Health Partners Sees Major EBITDA Turnaround and Raises Guidance for 2026
Market Chameleon (Fri, 15-May 3:06 AM ET)
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.
P3 Health Partners - Class A trades on the NASDAQ stock market under the symbol PIII.
As of September 25, 2026, PIII stock price was flat at $7.05 with 6,352 million shares trading.
PIII has a beta of -0.10, meaning it tends to be less sensitive to market movements. PIII has a correlation of 0.00 to the broad based SPY ETF.
PIII has a market cap of $27.58 million. This is considered a Sub-Micro Cap stock.
Last quarter P3 Health Partners - Class A reported $386 million in Revenue and -$.63 earnings per share. This beat revenue expectation by $9 million and exceeded earnings estimates by $1.27.
In the last 3 years, PIII traded as high as $96.50 and as low as $1.52.
The top ETF exchange traded funds that PIII belongs to (by Net Assets): VTI, VXF.
PIII has underperformed the market in the last year with a price return of -30.8% while the SPY ETF gained +18.4%. PIII has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -34.0% and -16.4%, respectively, while the SPY returned +5.3% and +1.2%, respectively.
PIII support price is $6.64 and resistance is $7.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PIII shares will trade within this expected range on the day.
